ID   MELK_MOUSE              Reviewed;         643 AA.
AC   Q61846; Q3TPU1; Q61804; Q6ZQH6;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   03-AUG-2022, entry version 180.
DE   RecName: Full=Maternal embryonic leucine zipper kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase PK38;
DE            Short=mPK38;
DE   AltName: Full=Tyrosine-protein kinase MELK;
DE            EC=2.7.10.2;
GN   Name=Melk; Synonyms=Kiaa0175, Pk38;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Keratinocyte;
RX   PubMed=9305775; DOI=10.1016/s0378-1119(97)00181-9;
RA   Gil M., Yang Y., Lee Y., Choi I., Ha H.;
RT   "Cloning and expression of a cDNA encoding a novel protein serine/threonine
RT   kinase predominantly expressed in hematopoietic cells.";
RL   Gene 195:295-301(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=C57BL/6 X DBA/2;
RX   PubMed=9136115;
RX   DOI=10.1002/(sici)1098-2795(199706)47:2<148::aid-mrd4>3.0.co;2-m;
RA   Heyer B.S., Warsowe J., Solter D., Knowles B.B., Ackerman S.L.;
RT   "New member of the Snf1/AMPK kinase family, Melk, is expressed in the mouse
RT   egg and preimplantation embryo.";
RL   Mol. Reprod. Dev. 47:148-156(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryo, and Spinal cord;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryonic tail;
RX   PubMed=14621295; DOI=10.1093/dnares/10.4.167;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S.,
RA   Saga Y., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: III.
RT   The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:167-180(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16061694; DOI=10.1083/jcb.200412115;
RA   Nakano I., Paucar A.A., Bajpai R., Dougherty J.D., Zewail A., Kelly T.K.,
RA   Kim K.J., Ou J., Groszer M., Imura T., Freije W.A., Nelson S.F.,
RA   Sofroniew M.V., Wu H., Liu X., Terskikh A.V., Geschwind D.H.,
RA   Kornblum H.I.;
RT   "Maternal embryonic leucine zipper kinase (MELK) regulates multipotent
RT   neural progenitor proliferation.";
RL   J. Cell Biol. 170:413-427(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-521, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [8]
RP   FUNCTION IN PHOSPHORYLATION OF MAP3K5, AND MUTAGENESIS OF LYS-40.
RX   PubMed=18948261; DOI=10.1074/jbc.m807219200;
RA   Jung H., Seong H.A., Ha H.;
RT   "Murine protein serine/threonine kinase 38 activates apoptosis signal-
RT   regulating kinase 1 via Thr 838 phosphorylation.";
RL   J. Biol. Chem. 283:34541-34553(2008).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-521, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-352, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in various processes
CC       such as cell cycle regulation, self-renewal of stem cells, apoptosis
CC       and splicing regulation. Has a broad substrate specificity;
CC       phosphorylates BCL2L14, CDC25B, MAP3K5/ASK1 and ZNF622. Acts as an
CC       activator of apoptosis by phosphorylating and activating MAP3K5/ASK1.
CC       Acts as a regulator of cell cycle, notably by mediating phosphorylation
CC       of CDC25B, promoting localization of CDC25B to the centrosome and the
CC       spindle poles during mitosis. Plays a key role in cell proliferation.
CC       Required for proliferation of embryonic and postnatal multipotent
CC       neural progenitors. Phosphorylates and inhibits BCL2L14. Also involved
CC       in the inhibition of spliceosome assembly during mitosis by
CC       phosphorylating ZNF622, thereby contributing to its redirection to the
CC       nucleus. May also play a role in primitive hematopoiesis.
CC       {ECO:0000269|PubMed:16061694, ECO:0000269|PubMed:18948261}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10027};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Activated by autophosphorylation of the T-loop at
CC       Thr-167 and Ser-171: in contrast to other members of the SNF1
CC       subfamily, phosphorylation at Thr-167 is not mediated by STK11/LKB1 but
CC       via autophosphorylation instead. Inhibited by calcium-binding. Kinase
CC       activity is also regulated by reducing agents: dithiothreitol (DTT) or
CC       reduced glutathione are required for kinase activity in vitro; such
CC       dependence is however not due to the presence of disulfide bonds (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer. Interacts with ZNF622 and PPP1R8 (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in testis, ovary, thymus, spleen and T-
CC       cell. Expressed by neural progenitors: highly enriched in cultures
CC       containing multipotent progenitors. {ECO:0000269|PubMed:16061694,
CC       ECO:0000269|PubMed:9136115, ECO:0000269|PubMed:9305775}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the 2-cell-stage embryo, followed by
CC       a strong expression at 8-cell-stage. {ECO:0000269|PubMed:9136115}.
CC   -!- DOMAIN: The KA1 domain mediates binding to phospholipids and targeting
CC       to membranes. {ECO:0000250}.
CC   -!- PTM: Autophosphorylated: autophosphorylation of the T-loop at Thr-167
CC       and Ser-171 is required for activation. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L76158; AAB72030.1; -; mRNA.
DR   EMBL; X95351; CAA64641.1; -; mRNA.
DR   EMBL; AK011932; BAB27923.1; -; mRNA.
DR   EMBL; AK145316; BAE26362.1; -; mRNA.
DR   EMBL; AK164138; BAE37644.1; -; mRNA.
DR   EMBL; AK129076; BAC97886.1; -; mRNA.
DR   EMBL; AL805952; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL807399; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS18124.1; -.
DR   RefSeq; NP_034920.2; NM_010790.2.
DR   PDB; 4BFM; X-ray; 2.35 A; A=1-326.
DR   PDB; 4CQG; X-ray; 2.57 A; A=1-326.
DR   PDBsum; 4BFM; -.
DR   PDBsum; 4CQG; -.
DR   AlphaFoldDB; Q61846; -.
DR   SMR; Q61846; -.
DR   BioGRID; 201390; 11.
DR   STRING; 10090.ENSMUSP00000043806; -.
DR   iPTMnet; Q61846; -.
DR   PhosphoSitePlus; Q61846; -.
DR   EPD; Q61846; -.
DR   jPOST; Q61846; -.
DR   MaxQB; Q61846; -.
DR   PaxDb; Q61846; -.
DR   PRIDE; Q61846; -.
DR   ProteomicsDB; 295853; -.
DR   Antibodypedia; 2095; 472 antibodies from 40 providers.
DR   DNASU; 17279; -.
DR   Ensembl; ENSMUST00000045607; ENSMUSP00000043806; ENSMUSG00000035683.
DR   GeneID; 17279; -.
DR   KEGG; mmu:17279; -.
DR   UCSC; uc008srv.1; mouse.
DR   CTD; 9833; -.
DR   MGI; MGI:106924; Melk.
DR   VEuPathDB; HostDB:ENSMUSG00000035683; -.
DR   eggNOG; KOG0583; Eukaryota.
DR   GeneTree; ENSGT00940000154889; -.
DR   HOGENOM; CLU_000288_157_8_1; -.
DR   InParanoid; Q61846; -.
DR   OMA; LRAHYNV; -.
DR   OrthoDB; 1127668at2759; -.
DR   PhylomeDB; Q61846; -.
DR   TreeFam; TF314032; -.
DR   BRENDA; 2.7.11.1; 3474.
DR   BioGRID-ORCS; 17279; 3 hits in 77 CRISPR screens.
DR   ChiTaRS; Melk; mouse.
DR   PRO; PR:Q61846; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q61846; protein.
DR   Bgee; ENSMUSG00000035683; Expressed in primitive streak and 218 other tissues.
DR   ExpressionAtlas; Q61846; baseline and differential.
DR   Genevisible; Q61846; MM.
DR   GO; GO:0005938; C:cell cortex; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; IDA:MGI.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; ISS:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0008283; P:cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0030097; P:hemopoiesis; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IDA:MGI.
DR   GO; GO:0061351; P:neural precursor cell proliferation; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IBA:GO_Central.
DR   CDD; cd14078; STKc_MELK; 1.
DR   InterPro; IPR028375; KA1/Ssp2_C.
DR   InterPro; IPR001772; KA1_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR034673; MELK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF02149; KA1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF103243; SSF103243; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50032; KA1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; ATP-binding; Calcium; Cell cycle; Cell membrane;
KW   Kinase; Lipid-binding; Membrane; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..643
FT                   /note="Maternal embryonic leucine zipper kinase"
FT                   /id="PRO_0000086324"
FT   DOMAIN          11..263
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          594..643
FT                   /note="KA1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00565"
FT   REGION          282..321
FT                   /note="UBA-like"
FT                   /evidence="ECO:0000250"
FT   REGION          326..643
FT                   /note="Autoinhibitory region"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        132
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         17..25
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         40
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         56
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         163
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         167
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         171
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         253
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         336
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         343
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         399
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         423
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         486
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         490
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         497
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         510
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MOD_RES         521
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:19144319"
FT   MOD_RES         531
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q14680"
FT   MUTAGEN         40
FT                   /note="K->R: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:18948261"
FT   CONFLICT        335
FT                   /note="L -> P (in Ref. 2; CAA64641 and 4; BAC97886)"
FT                   /evidence="ECO:0000305"
FT   HELIX           3..7
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   TURN            8..10
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   STRAND          11..19
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   STRAND          21..30
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   TURN            31..33
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   STRAND          36..43
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           44..47
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           48..51
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           52..62
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   STRAND          72..77
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   STRAND          79..87
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           94..101
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           106..125
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           135..137
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   STRAND          138..140
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   STRAND          146..148
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           172..174
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           188..204
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           214..223
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           234..243
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   TURN            248..250
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           254..258
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           261..264
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           284..294
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           298..305
FT                   /evidence="ECO:0007829|PDB:4BFM"
FT   HELIX           312..326
FT                   /evidence="ECO:0007829|PDB:4BFM"
SQ   SEQUENCE   643 AA;  72729 MW;  5637D2A4E8CFA216 CRC64;
     MKDYDELLKY YELYETIGTG GFAKVKLACH VLTGEMVAIK IMDKNALGSD LPRVKTEIDA
     LKSLRHQHIC QLYHVLETKN KIFMVLEYCP GGELFDYIIS QDRLSEEETR VVFRQILSAV
     AYVHSQGYAH RDLKPENLLF DENHKLKLID FGLCAKPKGN KDYHLQTCCG SLAYAAPELI
     QGKSYLGSEA DVWSMGILLY VLMCGFLPFD DDNVMALYKK IMRGKYEVPK WLSPSSILLL
     QQMLQVDPKK RISMRNLLNH PWVMQDYSCP VEWQSKTPLT HLDEDCVTEL SVHHRSSRQT
     MEDLISSWQY DHLTATYLLL LAKKARGKPA RLQLLSFSCG TASTTPKSKN LSLEDMSTSD
     DNCVAGLIDY ELCEDKLLAP KTPQVTKHLA ESNHAASKSP APGVRRAVAN KLMDKENVCT
     PKSSVKNEEQ FVFSEPKIPV SKNQYKREIP ASPTRFPTPA KARAQCLREA PVRTPGNSAG
     ADTLTTGVIS PERRCRSMDV DLNQAHMEDT PKKKGTNVFG SLERGLDKVL TALTRNKKKG
     SARDGPRKRK LHYNVTTTRL VNPDQLLSEI MAILPKKNVD FVQKGYTLKC QTQSDFGKVT
     MQFELEVCQL QRPDVVGIRR QRLKGDAWVY KRLVEDILSG CKM
//
